These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 11504778)

  • 21. Additive, but not synergistic antinociceptive effect of codeine and indomethacin combinations in the formalin test in the rat.
    Arredondo-Garza T; Lozano-Cuenca J; Jiménez-Andrade M; Castañeda-Hernández G
    Proc West Pharmacol Soc; 2007; 50():78-81. PubMed ID: 18605237
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mathematical formulation of additivity for antimicrobial agents.
    Boucher AN; Tam VH
    Diagn Microbiol Infect Dis; 2006 Aug; 55(4):319-25. PubMed ID: 16626903
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The additive interactions between ondansetron and droperidol for preventing postoperative nausea and vomiting.
    Chan MT; Choi KC; Gin T; Chui PT; Short TG; Yuen PM; Poon AH; Apfel CC; Gan TJ
    Anesth Analg; 2006 Nov; 103(5):1155-62. PubMed ID: 17056948
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antitumour effect of combination treatment with Sabarubicin (MEN 10755) and cis-platin (DDP) in human lung tumour xenograft.
    Bigioni M; Benzo A; Irrissuto C; Lopez G; Curatella B; Maggi CA; Manzini S; Crea A; Caroli S; Cubadda F; Binaschi M
    Cancer Chemother Pharmacol; 2008 Sep; 62(4):621-9. PubMed ID: 18038274
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Low folate conditions may enhance the interaction of trifluorothymidine with antifolates in colon cancer cells.
    Temmink OH; Hoogeland MF; Fukushima M; Peters GJ
    Cancer Chemother Pharmacol; 2006 Jan; 57(2):171-9. PubMed ID: 16010590
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The statistics of synergism.
    Slinker BK
    J Mol Cell Cardiol; 1998 Apr; 30(4):723-31. PubMed ID: 9602421
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Final amended report on the safety assessment of Methylparaben, Ethylparaben, Propylparaben, Isopropylparaben, Butylparaben, Isobutylparaben, and Benzylparaben as used in cosmetic products.
    Int J Toxicol; 2008; 27 Suppl 4():1-82. PubMed ID: 19101832
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Thermoregulatory response to an organophosphate and carbamate insecticide mixture: testing the assumption of dose-additivity.
    Gordon CJ; Herr DW; Gennings C; Graff JE; McMurray M; Stork L; Coffey T; Hamm A; Mack CM
    Toxicology; 2006 Jan; 217(1):1-13. PubMed ID: 16182429
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synergistic interaction between ouabain and 8-methoxy-3,9-dihydroxy coumestan, a non-steroidal synthetic inhibitor of Na+,K+-ATPase.
    Pôças ES; Touza NA; da Silva AJ; Costa PR; Noël F
    Life Sci; 2007 Sep; 81(15):1199-204. PubMed ID: 17884104
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A mathematical approach to study combined effects of toxicants in vitro: evaluation of the Bliss independence criterion and the Loewe additivity model.
    Goldoni M; Johansson C
    Toxicol In Vitro; 2007 Aug; 21(5):759-69. PubMed ID: 17420112
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interactions between drugs and occupied receptors.
    Tallarida RJ
    Pharmacol Ther; 2007 Jan; 113(1):197-209. PubMed ID: 17079019
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interactions in the tumor-promoting activity of carbon tetrachloride, trichloroacetate, and dichloroacetate in the liver of male B6C3F1 mice.
    Bull RJ; Sasser LB; Lei XC
    Toxicology; 2004 Jul; 199(2-3):169-83. PubMed ID: 15147791
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quantitative design of optimal analgesic combination of acetaminophen, caffeine, and butalbital.
    Zheng QS; Wang XW; Gui CQ; Sun RY
    Acta Pharmacol Sin; 2001 Aug; 22(8):691-6. PubMed ID: 11749839
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Towards a mechanism-based analysis of pharmacodynamic drug-drug interactions in vivo.
    Jonker DM; Visser SA; van der Graaf PH; Voskuyl RA; Danhof M
    Pharmacol Ther; 2005 Apr; 106(1):1-18. PubMed ID: 15781119
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ethyl methanesulfonate toxicity in Viracept--a comprehensive human risk assessment based on threshold data for genotoxicity.
    Müller L; Gocke E; Lavé T; Pfister T
    Toxicol Lett; 2009 Nov; 190(3):317-29. PubMed ID: 19443141
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The origin of informed consent].
    Mallardi V
    Acta Otorhinolaryngol Ital; 2005 Oct; 25(5):312-27. PubMed ID: 16602332
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The interaction index: a measure of drug synergism.
    Tallarida RJ
    Pain; 2002 Jul; 98(1-2):163-8. PubMed ID: 12098628
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quantitative design of drug compatibility by weighted modification method.
    Zheng QS; Sun RY
    Zhongguo Yao Li Xue Bao; 1999 Nov; 20(11):1043-51. PubMed ID: 11270973
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Testing drug additivity based on monotherapies.
    Yang H; Novick SJ; Zhao W
    Pharm Stat; 2015; 14(4):332-40. PubMed ID: 25962689
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Isobolographic analysis for combinations of a full and partial agonist: curved isoboles.
    Grabovsky Y; Tallarida RJ
    J Pharmacol Exp Ther; 2004 Sep; 310(3):981-6. PubMed ID: 15175417
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.